Developer docs
API playgroundTry for free, no card

Search company profiles

JD LYMON Group

Full company profile

uuid0009r68

Namestring
JD LYMON Group
Legal namestring
JD Lymon Group
Websiteurl
jdlymon.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

JD LYMON Group is a privately-held, boutique market access consulting firm headquartered in Mendota Heights, Minnesota (Minneapolis metro), founded in 2007 and operating with five partners and a small total headcount. The firm serves U.S. medical technology and biopharmaceutical companies across the full lifecycle of market access — from founders validating reimbursement pathways for prototypes to commercial teams optimizing coverage for marketed products. Its client base spans venture-backed startups, growth-stage MedTech companies, and Fortune 500 organizations, with named engagements including sleep apnea startups (ShiraTronics) and international MedTech companies entering the U.S. market (Nyxoah).

The firm's service portfolio consists of nine defined consulting offerings: reimbursement landscape assessments, CMS policy engagement, coding application development and submission (CPT, ICD-10, HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs, intraocular lens payment mechanisms), medical society engagement, coverage landscape overview, evidence review and generation planning, trial design and analysis, and clinical trial budget development. Delivery is built on the individual expertise of five partners — Jolayne Devers, Mark Domyahn, Carla Monacelli, John McInnes, and Amanda Cassidy — who collectively bring 125+ years of MedTech reimbursement experience spanning CMS, major device companies (Medtronic, Allergan, Zimmer, Nevro, LivaNova), and top healthcare law/policy firms (Arnold & Porter).

JD LYMON generates revenue through professional services engagements on a project or retainer basis, priced by scope and complexity with no public pricing disclosure. Go-to-market relies on a single-country (United States) direct enterprise consulting motion, with lead generation through the firm's website, LinkedIn presence of its partners, industry conference participation, and referral-driven business development within the healthcare consulting network. There is no proprietary technology platform, no AI/ML offering, no disclosed funding, and no parent company or institutional investors identified.

Short descriptiontext

JD LYMON Group is a boutique U.S. market access consulting firm serving medical technology and biopharmaceutical companies, providing reimbursement strategy, coding, CMS policy engagement, and coverage consulting across the product lifecycle to startups and Fortune 500 clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMendota Heights, United States
HQ citystring
Mendota Heights
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
market access consulting, medical device reimbursement, CMS policy advisory, MedTech strategy consulting, healthcare coding services
Industry1 code
PRIMARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Management Consulting Services54161
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Management Services8741
  • Services-Health Services8000
Product category
Healthcare Market Access Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Market Access Consulting Services
TypeProfessional Services
Description

JD Lymon Group provides specialized consulting services to medical technology and biopharmaceutical companies. Their revenue is generated through consulting engagements that span the full lifecycle of U.S. market access strategy, including reimbursement landscape assessments, CMS policy engagement, coding applications, and coverage strategy development. Services are tailored to each client's specific technology and business needs.

jdlymon.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

JD LYMON Group is a specialized market access consulting firm serving medical technology and biopharmaceutical companies across the full U.S. reimbursement lifecycle. The firm delivers reimbursement landscape assessments, CMS policy engagement, coding applications (CPT/ICD-10/HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs), medical society engagement, coverage analysis, evidence generation planning, trial design review, and clinical trial budget development.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Successfully established numerous Medicare payment mechanisms and obtained CPT, ICD-10, and HCPCS codes for emerging technologies
+1 more record
Product overview1 text field

JD Lymon Group is a specialized market access consulting firm offering a portfolio of reimbursement strategy services for MedTech and biopharmaceutical companies. The company provides nine distinct consulting service offerings spanning the full lifecycle of U.S. market access strategy, including reimbursement landscape assessments, CMS policy engagement, coding applications, incremental Medicare payment applications, medical society engagement, coverage landscape analysis, evidence generation planning, trial design, and clinical trial budget development. The firm serves four primary market segments: Medical Devices, Durable Medical Equipment (DME), SaaS and Digital Health Technologies, and Biologics and Orphan Therapies. The services are tailored to clients ranging from venture-backed startups to Fortune 500 organizations, addressing the interrelationships among health policy, reimbursement, and commercial execution.

Product and service1 record
1Reimbursement landscape assessments
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-23
Description

JD Lymon Group serves as an independent reimbursement consulting partner to Nyxoah, a Belgian medical technology company focused on obstructive sleep apnea solutions. At Nyxoah's Investor and Analyst Day, JD Lymon Group presents on the U.S. reimbursement landscape and the company's path to profitability for the Genio system launch. This represents an ongoing consulting engagement supporting U.S. commercial execution and market access strategy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

JD Lymon Group has worked with ShiraTronics, a venture-backed startup developing sleep apnea treatment devices, starting from the late development phase through the clinical phase. The firm has helped position the company for commercial launch with unique codes and a well-understood strategy for future payment and coverage, demonstrating their involvement in shaping market access strategy for emerging medical technologies.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Health Advances is a strategy consulting firm for MedTech and biopharma, with explicit practice areas in reimbursement strategy, market access, and payer engagement. Its service model and client base closely mirror JD LYMON's.

TypeDirect peer
Description

Avalere is a healthcare policy and market access consulting firm serving MedTech, biopharma, and health plan clients. It overlaps directly with JD LYMON in CMS policy engagement, coverage strategy, and reimbursement advisory, though it operates at a significantly larger scale.

3ZS Associates
TypeBroad incumbent
Description

ZS Associates is a large global consulting firm with a substantial healthcare and market access practice serving pharma and MedTech. While broader in scope than JD LYMON, it competes for the same enterprise reimbursement strategy mandates.

TypeBroad incumbent
Description

Huron is a large consulting firm with a healthcare practice covering strategy, operations, and revenue cycle/reimbursement advisory for providers and MedTech. It competes for larger reimbursement engagements that JD LYMON cannot fully staff.

TypeBroad incumbent
Description

Simon-Kucher is a global consulting firm with a life sciences practice covering pricing, market access, and reimbursement strategy. It competes with JD LYMON for biopharma and MedTech reimbursement engagements, especially for larger enterprise clients.

TypeDirect peer
Description

Evidera provides evidence generation, health economics, and market access consulting for life sciences manufacturers. It overlaps with JD LYMON's evidence review and generation planning as well as payer-facing strategy work.

TypeDirect peer
Description

Boston Healthcare Associates provides market access, reimbursement, and health economics consulting for medical device and biopharmaceutical manufacturers. It is one of the closest direct competitors in the medical device reimbursement strategy niche.

TypeDirect peer
Description

Xcenda is a market access and reimbursement consulting arm of Cencora (formerly AmerisourceBergen), serving life sciences manufacturers. It competes directly with JD LYMON on coding, coverage, and payer strategy for medical devices and specialty therapeutics.

TypeDirect peer
Description

MCRA is a medical device-focused consulting firm spanning reimbursement, regulatory, and clinical research services. It directly competes with JD LYMON's CMS policy engagement and coding/payment work for MedTech clients.

TypeEmerging player
Description

Argenta Advisors was a healthcare consulting firm co-founded by JD LYMON partner Carla Monacelli. It is a historical peer and partially overlapping service offering in reimbursement and government affairs consulting for life sciences.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JD LYMON Group

Healthcare Market Access Consultingjdlymon.com

JD LYMON Group is a boutique U.S. market access consulting firm serving medical technology and biopharmaceutical companies, providing reimbursement strategy, coding, CMS policy engagement, and coverage consulting across the product lifecycle to startups and Fortune 500 clients.

What JD LYMON Group does

JD LYMON Group is a privately-held, boutique market access consulting firm headquartered in Mendota Heights, Minnesota (Minneapolis metro), founded in 2007 and operating with five partners and a small total headcount. The firm serves U.S. medical technology and biopharmaceutical companies across the full lifecycle of market access — from founders validating reimbursement pathways for prototypes to commercial teams optimizing coverage for marketed products. Its client base spans venture-backed startups, growth-stage MedTech companies, and Fortune 500 organizations, with named engagements including sleep apnea startups (ShiraTronics) and international MedTech companies entering the U.S. market (Nyxoah).

The firm's service portfolio consists of nine defined consulting offerings: reimbursement landscape assessments, CMS policy engagement, coding application development and submission (CPT, ICD-10, HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs, intraocular lens payment mechanisms), medical society engagement, coverage landscape overview, evidence review and generation planning, trial design and analysis, and clinical trial budget development. Delivery is built on the individual expertise of five partners — Jolayne Devers, Mark Domyahn, Carla Monacelli, John McInnes, and Amanda Cassidy — who collectively bring 125+ years of MedTech reimbursement experience spanning CMS, major device companies (Medtronic, Allergan, Zimmer, Nevro, LivaNova), and top healthcare law/policy firms (Arnold & Porter).

JD LYMON generates revenue through professional services engagements on a project or retainer basis, priced by scope and complexity with no public pricing disclosure. Go-to-market relies on a single-country (United States) direct enterprise consulting motion, with lead generation through the firm's website, LinkedIn presence of its partners, industry conference participation, and referral-driven business development within the healthcare consulting network. There is no proprietary technology platform, no AI/ML offering, no disclosed funding, and no parent company or institutional investors identified.

JD LYMON Group firmographics

Firmographics
Name
JD LYMON Group
Legal name
JD Lymon Group
Website
https://jdlymon.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
JD LYMON Group is a boutique U.S. market access consulting firm serving medical technology and biopharmaceutical companies, providing reimbursement strategy, coding, CMS policy engagement, and coverage consulting across the product lifecycle to startups and Fortune 500 clients.
Ownership category
akta.pro rank

JD LYMON Group industry classification

Industry
Product category
Healthcare Market Access Consulting
NAICS
Management Consulting Services (54161), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Management Services (8741), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Market access consulting
  • Medical device reimbursement
  • CMS policy advisory
  • MedTech strategy consulting
  • Healthcare coding services

Where JD LYMON Group is headquartered

Location

Headquarters

HQ city
Mendota Heights
HQ country
United States
HQ region
North America

Offices1 record

Markets served

JD LYMON Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Market Access Consulting Services: JD Lymon Group provides specialized consulting services to medical technology and biopharmaceutical companies. Their revenue is generated through consulting engagements that span the full lifecycle of U.S. market access strategy, including reimbursement landscape assessments, CMS policy engagement, coding applications, and coverage strategy development. Services are tailored to each client's specific technology and business needs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

JD LYMON Group product offering

Product offering

Core offering

JD LYMON Group is a specialized market access consulting firm serving medical technology and biopharmaceutical companies across the full U.S. reimbursement lifecycle. The firm delivers reimbursement landscape assessments, CMS policy engagement, coding applications (CPT/ICD-10/HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs), medical society engagement, coverage analysis, evidence generation planning, trial design review, and clinical trial budget development.

Product overview

JD Lymon Group is a specialized market access consulting firm offering a portfolio of reimbursement strategy services for MedTech and biopharmaceutical companies. The company provides nine distinct consulting service offerings spanning the full lifecycle of U.S. market access strategy, including reimbursement landscape assessments, CMS policy engagement, coding applications, incremental Medicare payment applications, medical society engagement, coverage landscape analysis, evidence generation planning, trial design, and clinical trial budget development. The firm serves four primary market segments: Medical Devices, Durable Medical Equipment (DME), SaaS and Digital Health Technologies, and Biologics and Orphan Therapies. The services are tailored to clients ranging from venture-backed startups to Fortune 500 organizations, addressing the interrelationships among health policy, reimbursement, and commercial execution.

Differentiator

Problem solved

Functional benefit

Products and services

  • Reimbursement landscape assessments

Quantifiable outcome

  • Successfully established numerous Medicare payment mechanisms and obtained CPT, ICD-10, and HCPCS codes for emerging technologies
  • +1 more outcomes

Companies that use JD LYMON Group

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

JD LYMON Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

JD LYMON Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • NyxoahcoreStrategic or Co-development Partner · 23 June 2026JD Lymon Group serves as an independent reimbursement consulting partner to Nyxoah, a Belgian medical technology company focused on obstructive sleep apnea solutions. At Nyxoah's Investor and Analyst Day, JD Lymon Group presents on the U.S. reimbursement landscape and the company's path to profitability for the Genio system launch. This represents an ongoing consulting engagement supporting U.S. commercial execution and market access strategy.
  • ShiraTronicscoreStrategic or Co-development PartnerJD Lymon Group has worked with ShiraTronics, a venture-backed startup developing sleep apnea treatment devices, starting from the late development phase through the clinical phase. The firm has helped position the company for commercial launch with unique codes and a well-understood strategy for future payment and coverage, demonstrating their involvement in shaping market access strategy for emerging medical technologies.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

JD LYMON Group competitors and assessment

Company assessment

Direct peers

  • Health Advances: Health Advances is a strategy consulting firm for MedTech and biopharma, with explicit practice areas in reimbursement strategy, market access, and payer engagement. Its service model and client base closely mirror JD LYMON's.
  • Avalere Health: Avalere is a healthcare policy and market access consulting firm serving MedTech, biopharma, and health plan clients. It overlaps directly with JD LYMON in CMS policy engagement, coverage strategy, and reimbursement advisory, though it operates at a significantly larger scale.
  • Evidera (PPD, Thermo Fisher): Evidera provides evidence generation, health economics, and market access consulting for life sciences manufacturers. It overlaps with JD LYMON's evidence review and generation planning as well as payer-facing strategy work.
  • Boston Healthcare Associates: Boston Healthcare Associates provides market access, reimbursement, and health economics consulting for medical device and biopharmaceutical manufacturers. It is one of the closest direct competitors in the medical device reimbursement strategy niche.
  • Xcenda (Cencora): Xcenda is a market access and reimbursement consulting arm of Cencora (formerly AmerisourceBergen), serving life sciences manufacturers. It competes directly with JD LYMON on coding, coverage, and payer strategy for medical devices and specialty therapeutics.
  • MCRA (Medical Device Regulatory Advisors): MCRA is a medical device-focused consulting firm spanning reimbursement, regulatory, and clinical research services. It directly competes with JD LYMON's CMS policy engagement and coding/payment work for MedTech clients.

Broad incumbents

  • ZS Associates: ZS Associates is a large global consulting firm with a substantial healthcare and market access practice serving pharma and MedTech. While broader in scope than JD LYMON, it competes for the same enterprise reimbursement strategy mandates.
  • Huron Consulting Group: Huron is a large consulting firm with a healthcare practice covering strategy, operations, and revenue cycle/reimbursement advisory for providers and MedTech. It competes for larger reimbursement engagements that JD LYMON cannot fully staff.
  • Simon-Kucher & Partners: Simon-Kucher is a global consulting firm with a life sciences practice covering pricing, market access, and reimbursement strategy. It competes with JD LYMON for biopharma and MedTech reimbursement engagements, especially for larger enterprise clients.

Emerging players

  • Argenta Advisors: Argenta Advisors was a healthcare consulting firm co-founded by JD LYMON partner Carla Monacelli. It is a historical peer and partially overlapping service offering in reimbursement and government affairs consulting for life sciences.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

JD LYMON Group social profiles

Digital presence

JD LYMON Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JD LYMON Group leadership team

Management profile

Number of profiles

Profiles5 records

JD LYMON Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JD LYMON Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JD LYMON Group

What does JD LYMON Group do?

JD LYMON Group is a specialized market access consulting firm serving medical technology and biopharmaceutical companies across the full U.S. reimbursement lifecycle. The firm delivers reimbursement landscape assessments, CMS policy engagement, coding applications (CPT/ICD-10/HCPCS), incremental Medicare payment applications (NTAP, TPT, New Technology APCs), medical society engagement, coverage analysis, evidence generation planning, trial design review, and clinical trial budget development.

Is JD LYMON Group a public or private company?

JD LYMON Group is a private company. It is classified as management employee owned and is currently operating.

When was JD LYMON Group founded?

JD LYMON Group was founded in 2007. It employs 1 to 10 people.

Where is JD LYMON Group based?

JD LYMON Group is headquartered in Mendota Heights, United States, in the North America region.

How does JD LYMON Group make money?

One revenue line is on record: market Access Consulting Services.

Who are JD LYMON Group's main competitors?

Direct peers on record are Health Advances, Avalere Health, Evidera (PPD, Thermo Fisher), Boston Healthcare Associates, Xcenda (Cencora) and MCRA (Medical Device Regulatory Advisors). Broad incumbents are ZS Associates, Huron Consulting Group and Simon-Kucher & Partners. Argenta Advisors is listed as an emerging player.

Does JD LYMON Group have an API?

No public API is recorded for JD LYMON Group.

What industry is JD LYMON Group in?

JD LYMON Group's product category is Healthcare Market Access Consulting. Its primary akta.pro industry code is HLACANAN, DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA). Its NAICS code is 54161 and its SIC code is 8741.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals